Deutsche Bank analyst James Shin downgraded Merck (MRK) to Hold from Buy with a price target of $105, down from $128. The firm believes the ...

While immunotherapies have transformed treatment of many types of cancer, they do sometimes fail to have an impact – as Merck & Co has just observed in a study of Keytruda in head and neck cancer.

A subcutaneous formulation of MSD's top-selling cancer immunotherapy, Keytruda, was non-inferior to the current intravenous version in a head-to-head trial, setting up regulatory filings.

If your logo is well-designed, significant updates should be rare. Minor refinements every few years can keep it fresh. At a minimum, you'll want vector files (AI or EPS) and high-resolution PNGs and ...

If there's one thing that can instantly grab our attention and make a lasting impression, it's a well-crafted logo. Whether the sleek curves of Nike's iconic swoosh or the bold simplicity of Adidas' ...